1. Home
  2. RFL vs PRPL Comparison

RFL vs PRPL Comparison

Compare RFL & PRPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RFL
  • PRPL
  • Stock Information
  • Founded
  • RFL 2017
  • PRPL 2010
  • Country
  • RFL United States
  • PRPL United States
  • Employees
  • RFL N/A
  • PRPL N/A
  • Industry
  • RFL Real Estate
  • PRPL Home Furnishings
  • Sector
  • RFL Finance
  • PRPL Consumer Discretionary
  • Exchange
  • RFL Nasdaq
  • PRPL Nasdaq
  • Market Cap
  • RFL 74.4M
  • PRPL 78.9M
  • IPO Year
  • RFL N/A
  • PRPL N/A
  • Fundamental
  • Price
  • RFL $1.92
  • PRPL $0.80
  • Analyst Decision
  • RFL
  • PRPL Hold
  • Analyst Count
  • RFL 0
  • PRPL 2
  • Target Price
  • RFL N/A
  • PRPL $1.25
  • AVG Volume (30 Days)
  • RFL 202.8K
  • PRPL 839.4K
  • Earning Date
  • RFL 06-11-2025
  • PRPL 07-29-2025
  • Dividend Yield
  • RFL N/A
  • PRPL N/A
  • EPS Growth
  • RFL N/A
  • PRPL N/A
  • EPS
  • RFL N/A
  • PRPL N/A
  • Revenue
  • RFL $732,000.00
  • PRPL $456,844,000.00
  • Revenue This Year
  • RFL N/A
  • PRPL N/A
  • Revenue Next Year
  • RFL N/A
  • PRPL $10.65
  • P/E Ratio
  • RFL N/A
  • PRPL N/A
  • Revenue Growth
  • RFL 35.56
  • PRPL N/A
  • 52 Week Low
  • RFL $1.28
  • PRPL $0.56
  • 52 Week High
  • RFL $3.19
  • PRPL $1.50
  • Technical
  • Relative Strength Index (RSI)
  • RFL 47.49
  • PRPL 50.90
  • Support Level
  • RFL $1.82
  • PRPL $0.78
  • Resistance Level
  • RFL $2.16
  • PRPL $1.04
  • Average True Range (ATR)
  • RFL 0.13
  • PRPL 0.10
  • MACD
  • RFL -0.04
  • PRPL 0.01
  • Stochastic Oscillator
  • RFL 21.05
  • PRPL 36.36

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.

About PRPL Purple Innovation Inc.

Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms and other products. The Company has one reportable segment that operates an omni-channel distribution which allows the Company to offer a seamless shopping experience to its customers across multiple sales channels. It sells its products through its direct-to-consumer e-commerce channels, retail brick-and-mortar wholesale partners, Purple showrooms, and third-party online retailers.

Share on Social Networks: